06.10.2010Amsterdam Molecular Therapeutics successfully raised €14.3m through an Equity Issue

Amsterdam Molecular Therapeutics (AMT) Holding N.V. (Euronext: AMT) announces today that it has successfully raised € 14.3 m in gross proceeds through a private placement of new shares with institutional investors

Press Release

01.06.2010Advent Sells Respivert to J&J for Significant Cash Return

Centocor Ortho Biotech Inc. today announced that it has acquired RespiVert Ltd.

Press Release